A comprehensive view of vaccination/immunization. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Pfizer and Valneva to start late-stage clinical study of experimental VLA15 Lyme disease vaccination with 6,000 participants in US, northern Europe; in June, Pfizer invested US$92.3M in Valneva to support Lyme disease partnership
Published: August 10, 2022 by SeeNews Pharmaceuticals
Moderna and EU amend COVID-19 vaccine agreement to allow Spikevax deliveries scheduled for July, August to be delivered later in the year to allow EU members to receive Omicron-specific vaccines; EU to buy an additional 15 million vaccine doses
Published: August 10, 2022 by SeeNews Pharmaceuticals
Biontech reports Q2 net profits down at €1.7B from €2.8B a year ago, with revenue dropping to €3.2B from €5.3B a year ago; results driven by drop in revenue from COVID-19 vaccine as pandemic remains ‘dynamic’
Published: August 09, 2022 by BioNTech SE
Novavax starting Phase 2b/3 Hummingbird global clinical trial of its COVID-19 vaccine in children aged six months to 11 years old; trial to enroll 3,600 kids in US, Mexico, Europe, South America, Asia, Africa, with results by Q1 2023
Published: August 08, 2022 by M2 Pharma
Sanofi names Olivier Bogillot as head of US General Medicines responsible for serving diabetes, cardiovascular, transplant communities; Deborah Glasser named head of Vaccines, North America, to oversee US, Canada vaccine business
Published: August 08, 2022 by PR Newswire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count